tm
Seeing Is Believing
tm
Seeing Is Believing
CCCC is currently covered by 6 analysts with an average potential upside of $15.53 (151.29%) backed by displayed 8 price targets and 21 ratings.
Analysts average stock forecasts to be materialized ratio is 31.36% with an average time for these price targets to be met of 23.36 days.
Highest price target for CCCC is 23, Lowest price target is 1, average price target is 12.
Most recent stock forecast was given by TERENCE FLYNN from MORGAN STANLEY on 06-Nov-2023. First documented stock forecast 28-Oct-2020.
Currently, out of the existing stock ratings of CCCC - 4 which are a Hold (28.57%), 4 which are a Buy (28.57%), 6 which are a Sell (42.86%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Sell
1
$-0.57 (-36.31%)
3
23 days ago
3/4 (75%)
$-0.75 (-19.99%)
42
Buy
16
$14.43 (919.11%)
40
26 days ago
0/2 (0%)
$23.22 (662.51%)
Buy
51
3 months 18 days ago
0/1 (0%)
$6.36 (14.25%)
Buy
17
$15.14 (813.98%)
25
3 months 20 days ago
0/3 (0%)
$19.76 (375.56%)
Hold
5
$3.43 (218.47%)
6
3 months 20 days ago
1/5 (20%)
$2.74 (41.36%)
3
What is CCCC (C4 Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on CCCC (C4 Therapeutics) with a proven track record?
Which analyst has the most public recommendations on CCCC (C4 Therapeutics)?
Which analyst is the currently most bullish on CCCC (C4 Therapeutics)?
Which analyst is the currently most reserved on CCCC (C4 Therapeutics)?
